| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 56.193 | 409.198 | 405.545 | 338.301 | 419.884 | 497.834 | 247.482 |
| Total Income - EUR | - | - | - | 56.241 | 409.984 | 405.701 | 338.306 | 422.456 | 502.640 | 256.593 |
| Total Expenses - EUR | - | - | - | 86.430 | 312.803 | 261.432 | 254.620 | 438.306 | 666.838 | 300.347 |
| Gross Profit/Loss - EUR | - | - | - | -30.189 | 97.181 | 144.268 | 83.686 | -15.850 | -164.198 | -43.754 |
| Net Profit/Loss - EUR | - | - | - | -30.751 | 93.090 | 140.207 | 80.709 | -19.419 | -168.927 | -43.754 |
| Employees | - | - | - | 2 | 4 | 5 | 6 | 6 | 6 | 5 |
Check the financial reports for the company - Nova-Clin Medical Research Center S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 46.813 | 50.380 | 35.721 | 39.074 | 24.621 | 31.014 | 13.005 |
| Current Assets | - | - | - | 22.434 | 111.821 | 279.387 | 353.432 | 372.470 | 168.547 | 121.146 |
| Inventories | - | - | - | 4.207 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 10.948 | 106.505 | 262.671 | 328.907 | 351.907 | 159.529 | 99.830 |
| Cash | - | - | - | 7.279 | 5.316 | 16.717 | 24.525 | 20.564 | 9.018 | 21.316 |
| Shareholders Funds | - | - | - | -21.081 | 72.417 | 211.251 | 287.276 | 268.748 | 99.006 | 54.699 |
| Social Capital | - | - | - | 9.670 | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | 9.046 |
| Debts | - | - | - | 92.184 | 94.437 | 105.927 | 108.287 | 131.517 | 100.789 | 79.490 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nova-Clin Medical Research Center S.r.l.